Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate

Retrieved on: 2024-05-16 18:42:58

Tags for this article:

Click the tags to see associated articles and topics

Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate. View article details on hiswai:

Excerpt

Thursday, Genentech, a unit of Roche Holdings AG (OTC:RHHBY), released results from the Phase 1b trial of CT-388, a dual GLP-1/GIP receptor ...

Article found on: finance.yahoo.com